Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Dermatologic 1

Conditions

Colorectal Neoplasms 218Rectal Neoplasms 107Colonic Neoplasms 91Pancreatic Neoplasms 88Stomach Neoplasms 75Neoplasm Metastasis 61Esophageal Neoplasms 40Carcinoma, Hepatocellular 31Lymphoma 24Adenocarcinoma Of Esophagus 24Neoplasms 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Adenocarcinoma 19Leukemia 17Cholangiocarcinoma 15Biliary Tract Neoplasms 15Burkitt Lymphoma 14Gastrointestinal Neoplasms 12Lymphoma, Non-Hodgkin 11Osteosarcoma 9Liver Neoplasms 9Gallbladder Neoplasms 9Esophageal Squamous Cell Carcinoma 9Peritoneal Neoplasms 8Leukemia, Myeloid, Acute 8Myelodysplastic Syndromes 7Lymphoma, Large B-Cell, Diffuse 7Bile Duct Neoplasms 7Unspecified Adult Solid Tumor, Protocol Specific 6Multiple Myeloma 6

Interventions

sonidegib 2methyl 5-aminolevulinate 1folfirinox 1Taxes 1Risk Factors 1Oxaliplatin 1Lighting 1Leucovorin 1Irinotecan 1Infectious Disease Incubation Period 1HhAntag691 1Gemcitabine 1Fluorouracil 1Erlotinib Hydrochloride 1BF-200 ALA 1Aminolevulinic Acid 1Albumin-Bound Paclitaxel 15-aminolevulinic acid hexyl ester 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neoplasms, Basal Cell × Leucovorin × Clear all
NCT06483555 2026-04-23

PANGEA

UNC Lineberger Comprehensive Cancer Center

Phase 1/2 Recruiting
104 enrolled
DermatologicGastrointestinal

Pancreatic Neoplasms, Neoplasms, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡